The MSU Foundation-run Pre-Seed III Fund has secured an additional $6.5m from MEDC, more than a year after the vehicle was formed with $3m.

UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.

SoftBank’s Vision Fund returned for the $1bn funding round that valued the personal services platform operator at $15bn.

Mitsui and Nan Fung are among the backers celebrating Rallybio’s flotation on the Nasdaq Global Select Market following an $80.6m offering.

The GV-backed cardiovascular therapeutics company has priced an upsized offering on Nasdaq, with the shares closing just marginally higher on the first day.

The Sanofi Ventures-backed vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

GV was among the participants in a series C round that boosted the neurological communication technology developer's total funding to more than $360m.